Leo Pharma competitive analysis

Explore patent oppositions filed by Leo Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, And Percutaneously Absorbable Preparation Holding EquipmentBIOSERENTACHMay 8, 2019
Preparation For Application To Body Surface And Preparation Holding Sheet For Application To Body SurfaceBIOSERENTACHAug 15, 2018

Explore Leo Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
May 22, 2024An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis4
Sep 6, 2023Treatment Of Hand Eczema1
Jun 20, 2018Ointments For The Topical Treatment Of Psoriasis1
Jun 7, 2017Crystalline Ingenol Mebutate2
Aug 17, 2016Pharmaceutical Composition For Dermal Use To Treat Psoriasis, Sebopsoriasis Or Seborrhoic Dermatitis Comprising A Vitamin D And A Corticosteroid1
Dec 31, 2014A Pharmaceutical Spray Composition Comprising A Vitamin D Analogue And A Corticosteroid1

Latest PTAB cases involving Leo Pharma

Discover the latest PTAB cases involving Leo Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Leo Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LEO PHARMA210 - -
BIOSERENTACH - 5 - -
DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB35 - - -
GENERICS UK319 - - -